ARTICLE | Clinical News
FDA issues handful of new PDUFA dates
February 22, 2019 7:15 PM UTC
With the government shutdown resolved, FDA has accepted a handful of applications for review during the beginning Feb. 18, according to company announcements.
FDA granted Priority Review to two applications from Genentech Inc. for entrectinib and polatuzumab vedotin...